| Drug General Information |
| Drug ID |
D0K1NM
|
| Former ID |
DNC002719
|
| Drug Name |
1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone
|
| Drug Type |
Small molecular drug
|
| Indication |
Discovery agent
|
Investigative |
[1]
|
|---|
| Structure |
|
Download
2D MOL
3D MOL
|
| Formula |
C15H20N2O
|
| PubChem Compound ID |
|
| Target and Pathway |
| Target(s) |
Heme oxygenase |
Target Info |
Inhibitor |
[1]
|
|---|
|
BioCyc Pathway
|
Heme degradation
|
|
KEGG Pathway
|
Porphyrin and chlorophyll metabolism
|
|
HIF-1 signaling pathway
|
|
Mineral absorption
|
|
MicroRNAs in cancer
|
|
Pathway Interaction Database
|
Validated transcriptional targets of AP1 family members Fra1 and Fra2
|
|
HIF-1-alpha transcription factor network
|
|
PathWhiz Pathway
|
Porphyrin Metabolism
|
|
Reactome
|
Iron uptake and transport
|
|
WikiPathways
|
Oxidative Stress
|
|
Transcriptional activation by NRF2
|
|
NRF2 pathway
|
|
Nuclear Receptors Meta-Pathway
|
|
miR-targeted genes in squamous cell - TarBase
|
|
miR-targeted genes in muscle cell - TarBase
|
|
miR-targeted genes in lymphocytes - TarBase
|
|
miR-targeted genes in leukocytes - TarBase
|
|
miR-targeted genes in epithelium - TarBase
|
| References |
| REF 1 | The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. |
|---|
